Survey helps identify diagnostic misconception in Latino study participants by Kocarnik, Jonathan
September 21, 2015 SCIENCE SPOTLIGHT 
 
1 Volume 5, Issue 9 | Fred Hutchinson Cancer Research Center 
 
Survey helps identify diagnostic misconception 
in Latino study participants 
September 21, 2015 






Biological specimens are increasingly collected 
and stored for population health research. 
 





Researchers conducting observational studies are increasingly collecting biological samples to help 
understand and improve population-level health and disease management.  While collectively useful, 
the results from any given participant's sample are generally not clinically meaningful, and so are 
generally not made available.  Despite this distinction, some research participants mistakenly expect 
that donating biological samples may benefit them personally by providing meaningful health 
information.  Identifying participants susceptible to such misconceptions would help ensure ethical 
recruitment in biospecimen research projects, particularly in underserved populations.  In a recent 
report in BMC Medical Ethics, Drs. Sarah Knerr and Rachel Ceballos in the Public Health Sciences 
Division describe a new survey instrument they developed to systematically measure conflation of 
biospecimen-based research and clinical care for use with Latino communities. 
Research participants’ expectations of receiving personal health benefits when participating in 
observational studies have been termed diagnostic misconception.  This is an extension of the 
concept of therapeutic misconception, most common in clinical trials, where trial participants 
misunderstand the different goals and principles governing research compared to clinical 
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care.  These misunderstandings can alter participants' perceptions of the balance of potential 
benefits and burdens of research participation, which in turn can impact the effectiveness of the 
informed consent process and the decision whether to participate. "With the increasing focus on 
developing precision and patient-centered medicine the line between research and clinical care will 
likely get blurrier," said lead author Dr. Knerr.  "It is important for the research community to think 
through the implications of what this means for our participants." 
Of particular importance is evaluating the extent and impact of diagnostic misconception in 
communities that have limited health care access.  These populations may be more strongly affected 
by the negative consequences of misunderstandings about research and clinical care, which could 
damage trust in both doctors and researchers.  Furthermore, diagnostic misconception could 
potentially motivate project participation if health care is otherwise inaccessible due to false beliefs 
that research participation can substitute for medical care. Said Knerr, "We were inspired to create 
this instrument by observations we made analyzing data from a prior research study Dr. Ceballos 
conducted with Latinos living on the US-Mexico border.  During interviews about biomedical 
research participation, people often described 'getting checked' as a main benefit of providing a 
sample for research, even though our interview guide had initially explained the differences between 
providing samples for research versus clinical care." 
To enable future research on the causes and consequences of such misconceptions, the authors 
developed a quantitative survey instrument measuring conflation of observational biospecimen-
based research and clinical care. This involved developing 20 questions pertaining to participants’ 
understanding of the difference between observational research and clinical trials, the purpose of 
biospecimen-based research, and the perceived likelihood of benefiting personally from 
participation. By piloting these questions with 150 Latino adults in the lower Yakima Valley of 
Washington state and performing psychometric analyses, the authors identified the combination of 
questions that best measured conflation of research and clinical care. The authors also found that 
individuals with the highest scores on the final instrument, indicating the greatest conflation of 
biospecimen-based research and clinical care, were unemployed, spoke only Spanish, had no 
health insurance, had less access to traditional health care, and had good self-rated health.  Future 
biospecimen-based research studies may be able to modify their recruitment and informed consent 
processes in order to help clarify misunderstandings about research and clinical care, particularly for 
subgroups that may be more likely to have misconceptions about research. 
While a good first step, further research is needed to refine the instrument and assess its 
generalizability in more diverse communities and settings.  Said Dr. Knerr, "the most pressing 
September 21, 2015 SCIENCE SPOTLIGHT 
 
3 Volume 5, Issue 9 | Fred Hutchinson Cancer Research Center 
 
questions that this work raises are ethical ones about research recruitment and informed decision-
making in communities that have poor access to health care, who are often also underrepresented in 
population-based biobanks and targeted for special recruitment efforts. How much do they know 
about biobanking and observational research? How likely are they to conflate research and clinical 
care and does this influence their decisions to take part in research studies? Is this coercive? What 
can we do about it?"  Answering these questions will be important for ensuring that all populations 
are able to appropriately participate and benefit from biospecimen research. 
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